A complicated case of neuroleptic malignant syndrome was successfully treated with a higher dose of bromocriptine and lorazepam.
Higher-dose bromocriptine plus lorazepam may aid refractory NMS; leaves open need for controlled trials before practice change.
A 53-year-old patient of schizoaffective disorder developed neuroleptic malignant syndrome (NMS) following treatment with haloperidol, clozapine and parenteral fluphenazine. He showed full recovery with immediate discontinuation of potential offenders and prompt treatment with a higher dose of bromocriptine and lorazepam along with management of aspiration pneumonia. Need for early recognition of NMS and treatment by a multidisciplinary team is discussed. How to cite this article Sharma R, Kashyap R. Successful Treatment of a Complicated Case of Neuroleptic Malignant Syndrome with a Higher Dose of Bromocriptine and Lorazepam. J Postgrad Med Edu Res 2015;49(2):88-90.
No takes yet. Share an insight, caveat, or question.
Rajesh Kashyap (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: